Success Metrics

Active Trials
3(75%)

Phase Distribution

Ph phase_2
1
25%
Ph not_applicable
1
25%
Ph phase_3
2
50%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Active, not recruiting3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 21 (25.0%)
Phase 32 (50.0%)
N/A1 (25.0%)

Trials by Status

active_not_recruiting375%
unknown125%

Recent Activity

Clinical Trials (4)

Drug Details

Intervention Type
RADIATION
Total Trials
4